Analyst Price Targets — CLOV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 21, 2025 8:11 am | Whit Mayo | Leerink Partners | $3.00 | $2.92 | StreetInsider | Clover Health (CLOV) PT Raised to $3 at Leerink Partners |
| December 17, 2024 12:18 pm | Matt Hewitt | Craig-Hallum | $6.00 | $3.16 | TheFly | Clover Health initiated with a Buy at Craig-Hallum |
| August 6, 2024 8:17 am | Richard Close | Canaccord Genuity | $2.50 | $1.86 | StreetInsider | Clover Health (CLOV) PT Raised to $2.50 at Canaccord Genuity |
| November 16, 2022 7:51 am | — | Citigroup | $1.80 | $1.44 | Benzinga | Citigroup Maintains Neutral on Clover Health Investments, Lowers Price Target to $1.8 |
Latest News for CLOV
Strata Skin Sciences (NASDAQ: SSKN - Get Free Report) and Clover Health Investments (NASDAQ: CLOV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings. Institutional and Insider Ownership 32.4%
CLOV Q4 loss matches estimates. Revenues jump 45%.
Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript
Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year Achieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retention Expect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full…
Strata Skin Sciences (NASDAQ: SSKN - Get Free Report) and Clover Health Investments (NASDAQ: CLOV - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Strata
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLOV.
U.S. House Trading
No House trades found for CLOV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.